Eli Lilly And Co. (LLY) News Headlines

▮ More

Date

Headline

5/22/2019 6:32:55 AM Eli Lilly Reports Availability Of Insulin Lispro Injection

5/13/2019 7:10:07 AM Eli Lilly Announces FDA Approval Of CYRAMZA For New Indication - Quick Facts

5/13/2019 6:50:09 AM Lilly: FDA Approves CYRAMZA In Patients With Hepatocellular Carcinoma

5/9/2019 6:31:45 AM Elanco Animal Health Q1 Net Income Decline To $31.5 Mln Or $0.09 Per Share

5/8/2019 6:50:40 AM Lily Announces New Data And Post-hoc Analyses For Lasmiditan At AAN 2019

5/6/2019 3:07:56 PM Eli Lilly And Co. (LLY) Declares $ 0.645 Dividend for Q2 19, Record Date 5/17/2019

5/2/2019 6:47:18 AM Lilly To Present New Data At AAN 2019 On Emgality And Lasmiditan Reinforcing Breadth Of Headache Disorders Portfolio

4/30/2019 8:07:16 AM Incyte To No Longer Participate In Co-funding Of Development Of Baricitinib

4/30/2019 6:51:54 AM Eli Lilly Updates 2019 Guidance To Reflect Elanco Disposition - Quick Facts

4/30/2019 6:30:29 AM Eli Lilly And Co. (LLY) Has Raised Its FY19 EPS Estimate To 5.60 - 5.70 From 5.55 - 5.65

4/30/2019 6:29:54 AM Eli Lilly And Co. (LLY) Has Lowered Its FY19 Revenue Estimate To $22.0 - $22.5 Bln From $25.1 - $25.6 Bln

4/30/2019 6:29:04 AM Eli Lilly And Co. Q1 adjusted earnings Beat Estimates

4/30/2019 6:26:09 AM Eli Lilly Q1 Non-GAAP EPS $1.33 Vs $1.31 Last Year

4/25/2019 6:47:10 AM Lilly To Form Access Program For Patients As It Prepares To Withdraw Lartruvo From Market

4/22/2019 11:46:47 PM Lilly To Sell Legacy Antibiotics Brands And Manufacturing Facility In China

4/22/2019 11:29:58 PM Lilly Announces Sale Of Legacy Antibiotics Brands And Manufacturing Facility In China

4/22/2019 7:46:54 AM Eli Lilly Reports Positive Top-line Results From Phase 3 Study Of Taltz

4/22/2019 7:00:29 AM Eli Lilly, Avidity Collaborate To Develop New Medicines In Immunology

4/22/2019 6:45:58 AM Lilly Announces Positive Top-Line Results For COAST-X

4/22/2019 6:36:26 AM Lilly And Avidity Biosciences Announce Licensing And Research Collaboration